Doxorubicin and Olaratumab Versus Doxorubicin, Ifosfamide, and Mesna for Treatment of Advanced Soft Tissue Sarcomas
- Kathryn J. Hammer
- , Vanessa C. Copeland
- , Elizabeth T. Loggers
- , Seth M. Pollack
- , Michael J. Wagner
- , Lee D. Cranmer
Research output: Contribution to journal › Article › peer-review
6
Link opens in a new tab
Scopus
citations